Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above | classic Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2026-05-14 | NCT05404945 |